Stonebridge Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Stonebridge Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12	Closed	-$5.25K	–	496
2023 Q3	$5.25K	Hold	12	–	–	﹤0.01%	704
2023 Q2	$6.03K	Buy	+12	New	+$5.75K	﹤0.01%	690
2022 Q4	–	Sell	-4	Closed	-$1K	–	1045
2022 Q3	$1K	Buy	+4	New	+$1.47K	﹤0.01%	906
2022 Q2	–	Sell	-2	Closed	-$1K	–	989
2022 Q1	$1K	Hold	2	–	–	﹤0.01%	965
2021 Q4	$1K	Hold	2	–	–	﹤0.01%	914
2021 Q3	$1K	Buy	+2	New	+$1.34K	﹤0.01%	893

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Stonebridge Capital Advisors's IDXX Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 12 shares — an estimated $5.25K sold.

Stonebridge Capital Advisors first reported a position in IDXX in Q3 2021 and held it in 6 quarters. The position peaked at $6.03K in Q2 2023. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

Stonebridge Capital Advisors reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 12 Idexx Laboratories shares in Q4 2023, an estimated $5.25K.
Stonebridge Capital Advisors first reported a position in Idexx Laboratories in Q3 2021 and held it in 6 quarters.
Stonebridge Capital Advisors's Idexx Laboratories position peaked at $6.03K in Q2 2023.
1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.